top of page

Focus on advances in oncology vaccines

PSCC Thursday of January 11, 2024, the replay is available!

Olivier LANTZ, Institut Curie

Holder of a doctorate in medicine and a doctorate from the University of Paris XI. He was an associate professor of medicine at Paris-Sud University before joining the Institut Curie in 2000. Since then, he has directed the clinical immunology laboratory at the Institut Curie hospital in Paris and a research group in fundamental immunology within this research center.

Silvia COMIS, Ose Immunotherapeutics

Holder of a doctorate in medicine. She was Senior Medical Director at IQVIA and European Head of Medical Affairs for Early Oncology Products at Novartis. Most recently, she joined Ose ImmunoTherapeutics as Head of Clinical Development and Regulatory Affairs.

Jean-Christophe DANTONEL, iBionext

Holder of a doctorate in molecular biology and an MBA in finance, strategy & economics. After more than 10 years in biological and medical science, including 6 years as an assistant professor at INSERM, he worked as an advisor to the Ministry of Research and Higher Education. He then spent 13 years as director of the health and biotechnology division of the General Secretariat for Investment (SGPI). More recently, he joined iBionext as Managing Director

See the replay below


bottom of page